Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...

Transvenous leads are the most common source of complications associated with the use of implantable cardioverter-defibrillators (ICDs). A preliminary experience with an entirely subcutaneous ICD ...

Please provide your email address to receive an email when new articles are posted on . An entirely subcutaneous implantable cardioverter defibrillator system was found to successfully and ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

NICE, FRANCE – A longer-term assessment of a new subcutaneous implantable cardioverter defibrillator (ICD) (Boston Scientific) shows that just over 90% of patients are free from complications at two ...

Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...

Stockholm, Sweden - Early testing of an implantable cardioverter-defibrillator (ICD) featuring a totally subcutaneous lead system suggests the device can terminate ventricular tachyarrhythmias using ...

The FDA’s Circulatory System Devices panel voted 7-1 on Thursday that the benefits of the Cameron Health subcutaneous ICD system (S-ICD) outweigh the risks in appropriately selected patients. The ...

Last year the FDA approved Boston Scientific's subcutaneous ICD, the first ICD that can defibrillate the heart without using leads threaded to the heart through the blood vessels. Those leads are the ...

The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing ...

This week, a nice article in the Boston Globe appeared on Boston Scientific’s subcutaneous implantable cardiac defibrillator (S-ICD) that recently received FDA approval. It was a fairly balanced ...

HRS: iPad2 Can Trigger Magnet Mode in Defibrillators The subcutaneous implantable cardioverter-defibrillator (S-ICD System) is both safe and effective for the treatment of life-threatening ventricular ...